Cardio-Renal Drugs Advisory Cmte.
Executive Summary
Four hypertension drugs on the agenda for Dec. 16-17 meeting at Natl. Institutes of Health Lister Hill Auditorium. Drugs for review are (1) guanfacine (Robins), (2) Procardia, nifedipine (Pfizer) for immediate reduction of dangerously high blood pressure, (3) Vasoretic, enalapril plus hydrochlorothiazide, (Merck), and (4) Tranzide and Normozide, labetolol plus hydrochlorothiazide (Glaxo and Schering). Pre-registration for the meeting is required. Contact Mae Brooks 301-443-4695.